FSANZ Report Highlights Regulatory Shifts in ANZ Food and Supplement Sector
The latest annual report from Food Standards Australia New Zealand (FSANZ) outlines key regulatory advancements and future focusses. It signals significant developments in food and potentially supplement standards, including novel foods and labelling accuracy.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
FSANZ Annual Report Unpacks Key Regulatory Developments for Australia and New Zealand
Food Standards Australia New Zealand (FSANZ) has published its 2024–25 Annual Report, offering a comprehensive overview of the regulatory landscape for food and, by extension, the broader supplement industry in Australia and New Zealand. As a contract manufacturer, we scrutinise such reports closely; they provide crucial insights into the evolving demands placed on product formulation, safety, and labelling.
Dr. Sandra Cuthbert, CEO of FSANZ, highlighted a year of significant regulatory and scientific progress, attributing success to strong collaboration across the Food Regulation System. For manufacturers like us, this collaborative approach is vital as it shapes the environment in which we operate, from raw material sourcing to final product release. The report confirms that FSANZ finalised 20 applications and seven proposals, all geared towards advancing food standards and maintaining consumer trust.
“We finalised 20 applications and 7 proposals that advanced food standards and helped maintain trust in the safety of our food supply,” Dr Cuthbert said, as reported by FSANZ.
Of particular interest to supplement manufacturers are the advancements in new and emerging areas of food regulation. The report specifically mentions the approval of the first cell-cultured food for sale in Australia and New Zealand, alongside updated definitions for genetically modified food. This development is a significant harbinger; while cell-cultured products currently sit within the food category, the regulatory pathway established could well influence how novel ingredients intended for supplements are assessed and approved in the future. Brand owners contemplating innovative new products should be keenly aware of these early precedents.
Beyond novel foods, the report also detailed ongoing work to strengthen egg safety standards and a review of the Health Star Rating system and nutrition information panels. From a formulation standpoint, the latter is particularly relevant. Clear, accurate labelling is paramount in the supplement sector. Any changes to the display or calculation of nutritional information could necessitate adjustments to packaging designs and internal quality control processes for our brand partners, ensuring compliance and clear communication to consumers.
FSANZ's continued focus on its core functions, including coordinating 87 food recalls and managing 10 significant food safety issues, underscores the enduring importance of robust quality management systems throughout the supply chain. For contract supplement manufacturers, this reinforces the critical role of GMP compliance and stringent testing protocols. Furthermore, strengthening international partnerships, including collaborative assessments with Health Canada and new science dialogues across the Asia–Pacific region, suggests a harmonisation trend. This means that what happens in one market could increasingly influence others, prompting a more globally minded approach to product development and market entry for supplement brands.
Many leading brands in this category are manufactured in partnership with Supplement Factory.